product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
Phospho-A-Raf (Ser299) Antibody
catalog :
4431
clonality :
polyclonal
host :
rabbit
conjugate :
nonconjugated
antigen modification :
phosphorylated
reactivity :
human, mouse, rat
application :
western blot, reverse phase protein lysate microarray
citations: 3
Published Application/Species/Sample/DilutionReference
  • reverse phase protein lysate microarray; human; loading ...; fig st6
Cherniack A, Shen H, Walter V, Stewart C, Murray B, Bowlby R, et al. Integrated Molecular Characterization of Uterine Carcinosarcoma. Cancer Cell. 2017;31:411-423 pubmed publisher
  • western blot; human; 1:500; loading ...; fig 3b
Awad K, Elinoff J, Wang S, Gairhe S, Ferreyra G, Cai R, et al. Raf/ERK drives the proliferative and invasive phenotype of BMPR2-silenced pulmonary artery endothelial cells. Am J Physiol Lung Cell Mol Physiol. 2016;310:L187-201 pubmed publisher
Tap W, Gong K, Dering J, Tseng Y, Ginther C, Pauletti G, et al. Pharmacodynamic characterization of the efficacy signals due to selective BRAF inhibition with PLX4032 in malignant melanoma. Neoplasia. 2010;12:637-49 pubmed
product information
SKU :
4431S
Product-Name :
Phospho-A-Raf (Ser299) Antibody
Size :
100 ul
Price-(USD) :
274 USD
Species-x-Reactivity :
H, M, R
Applications :
Western blot
Product-Category :
MAP Kinase Signaling
Shipping-Temp :
AMBIENT
Storage-Temp :
-20°C
Product-Type :
Polyclonal Antibody
MW :
68
Host :
Rabbit
Target :
A-Raf (Ser299) phosphate
Primary-Protein :
A-Raf
Alt-Names :
A-RAF,A-Raf proto-oncogene serine/threonine-protein kinase,ARAF,ARAF1,Oncogene ARAF1,PKS,PKS2,Proto-oncogene A-Raf,Proto-oncogene A-Raf-1,Proto-oncogene Pks,RAFA1,Ras-binding protein DA-Raf,Serine/threonine-protein kinase A-Raf,v-raf murine sarcoma 3611 viral oncogene homolog,v-raf murine sarcoma 3611 viral oncogene homolog 1
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.